WINTON GROUP Ltd Reduces Stock Position in Merit Medical Systems, Inc. $MMSI

WINTON GROUP Ltd cut its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 7.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 147,589 shares of the medical instruments supplier’s stock after selling 11,194 shares during the quarter. WINTON GROUP Ltd owned approximately 0.25% of Merit Medical Systems worth $10,234,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of MMSI. Kilter Group LLC purchased a new position in shares of Merit Medical Systems during the second quarter valued at approximately $25,000. Los Angeles Capital Management LLC purchased a new stake in Merit Medical Systems in the fourth quarter worth $25,000. Covestor Ltd lifted its stake in Merit Medical Systems by 252.6% in the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 336 shares during the period. Danske Bank A S bought a new stake in Merit Medical Systems in the third quarter valued at $42,000. Finally, Quarry LP boosted its holdings in Merit Medical Systems by 185.9% in the third quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock valued at $44,000 after acquiring an additional 342 shares in the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Stock Down 0.2%

Shares of Merit Medical Systems stock opened at $87.19 on Thursday. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The company has a 50-day moving average of $82.95 and a 200 day moving average of $73.29. The firm has a market cap of $5.21 billion, a price-to-earnings ratio of 36.03, a PEG ratio of 2.18 and a beta of 0.49. Merit Medical Systems, Inc. has a 1 year low of $59.74 and a 1 year high of $94.75.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping the consensus estimate of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The business had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. During the same quarter in the previous year, the firm posted $1.01 earnings per share. Merit Medical Systems’s quarterly revenue was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, sell-side analysts anticipate that Merit Medical Systems, Inc. will post 3.84 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MMSI has been the subject of several research reports. Needham & Company LLC upped their price objective on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Piper Sandler lifted their target price on shares of Merit Medical Systems from $96.00 to $106.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Raymond James Financial reiterated an “outperform” rating and set a $100.00 price target on shares of Merit Medical Systems in a research report on Friday, July 31st. JPMorgan Chase & Co. increased their price target on shares of Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Finally, Canaccord Genuity Group raised their price objective on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a “buy” rating in a report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $100.00.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.